SCHEMBL449018

SCHEMBL449018

CN(NC(=O)CS(=O)(=O)NN(C)C(=S)c1ccccc1F)C(=S)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 2/20 0.55
HSP90AB1 P08238 1/20 0.55
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
HTT P42858 1/20 0.36
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
ALDH1A1 P00352 4/20 0.35
HPGD P15428 2/20 0.35
MAPT P10636 2/20 0.35
ALOX12 P18054 1/20 0.34
PTPN1 P18031 1/20 0.34
ERCC5 P28715 1/20 0.34
FEN1 P39748 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL447714 1.00 HSP90AA1 (0.55) HSP90AA1HSP90AB1MEN1KMT2ACYP1A2
SCHEMBL464655 0.89 HSP90AA1 (0.68) HSP90AA1HSP90AB1MEN1KMT2ACYP3A4
SCHEMBL2476616 0.86 HSP90AA1 (0.52) HSP90AA1HSP90AB1MEN1KMT2ACYP1A2
SCHEMBL446362 0.83 HSP90AA1 (0.63) HSP90AA1HSP90AB1MEN1KMT2AALDH1A1
SCHEMBL445761 0.83 HSP90AA1 (0.59) HSP90AA1HSP90AB1KMT2AHTTNPC1
SCHEMBL445596 0.83 HSP90AA1 (0.59) HSP90AA1HSP90AB1MEN1KMT2ACYP1A2
SCHEMBL2476428 0.83 HSP90AA1 (0.53) HSP90AA1HSP90AB1ALDH1A1MAPT
SCHEMBL451123 0.81 HSP90AA1 (0.50) HSP90AA1HSP90AB1MEN1KMT2ACYP1A2
SCHEMBL447290 0.81 HSP90AA1 (0.51) HSP90AA1HSP90AB1MEN1KMT2ACYP1A2
SCHEMBL446749 0.81 HSP90AA1 (0.59) HSP90AA1HSP90AB1MEN1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680100-B2 Sulfonylhydrazide compounds for treating proliferative disorders SYNTA PHARMACEUTICALS CORP. (US) 2014-03-25 US disclosed
US-20120065206-A1 COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS SYNTA PHARMACEUTICALS CORP. (US) 2012-03-15 US disclosed
US-20120065066-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-03-15 US disclosed
EP-2370402-A2 COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS Synta Pharmaceuticals Corp. (US) 2011-10-05 EP disclosed
WO-2010065512-A2 COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS SYNTA PHARMACEUTICALS CORP. (US) 2010-06-10 WO disclosed
WO-2010065512-A2 COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS SYNTA PHARMACEUTICALS CORP. (US) 2010-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120065066-A1 NOVEL HERBICIDES DDT, CYP4X1, CYP1B1 HSP90AA1 892/4885HSP90AB1 794/4885MEN1 4280/4885
US-20120065206-A1 COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS PKD1, PKD2, PCNA HSP90AA1 2300/4885HSP90AB1 1711/4885MEN1 89/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.